Amanote Research
Register
Sign In
Prs27 - Economic Burden of Idiopathic Pulmonary Fibrosis (Ipf) in China
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2421
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
W. Feng
J. Xuan
Y. Zhang
Y. Lu
M. Ren
F. Fan
H. Kang
R. Chen
Q. Luo
Q. Han
H. Dai
B. Xie
Publisher
Elsevier BV
Related search
Prs33 - The Clinical and Economic Burden of Idiopathic Pulmonary Fibrosis in Algeria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Idiopathic Pulmonary Fibrosis (IPF) ― Common Practice in Poland Before the “Antifibrotic Drugs Era”
Advances in Respiratory Medicine
Pulmonary
Respiratory Medicine
Idiopathic Pulmonary Fibrosis
Pulmonologiya
Pulmonary
Respiratory Medicine
Idiopathic Pulmonary Fibrosis in Sweden: Report From the First Year of Activity of the Swedish IPF-Registry
European Clinical Respiratory Journal
Idiopathic Pulmonary Fibrosis
Differing Severities of Acute Exacerbations of Idiopathic Pulmonary Fibrosis (IPF): Insights From the INPULSIS® Trials
Respiratory Research
Pulmonary
Respiratory Medicine
Epigenomics of Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Direct Medical Costs of Hospitalized Patients With Idiopathic Pulmonary Fibrosis in China
Managing Comorbidities in Idiopathic Pulmonary Fibrosis
International Journal of General Medicine
Medicine
